National Instruments Corporation

Practice Area: 
Stock Symbol: 
Case Status: 

Ademi LLP is investigating NI (NASDAQ: NATI) for possible breaches of fiduciary duty and other violations of law in its transaction with Alliance.

Ademi LLP alleges NI’s financial outlook and prospects are excellent and yet NI’s shareholders are expected to receive only $60 per share in cash at an equity value of $8.2 billion. The transaction agreement unreasonably limits competing bids for NI by imposing a significant penalty if NI accepts a superior bid. NI insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of NI’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for NI.